Novel Coronavirus (SARS-CoV-2/COVID-19)
Augusta Health, in Fishersville, Virginia, partnered with the Allegheny Mountain Institute to create the AMI Farm at Augusta Health, which provides food for use at the hospital, serves as a hub for nutrition and sustainable agriculture education and offers nutrient-dense foods to community members…
Since the COVID-19 pandemic arrived in the U.S. nearly 10 months ago, our hospitals and health systems have learned so much about how to slow down the spread, care for patients and help them recover.
To continue emphasizing the message of protecting against both the flu and COVID-19, AHA’s Wear A Mask and United Against the Flu campaigns released new resources, including new sample social media messages and graphics that hospitals and health systems can use to reiterate the importance of…
The AHA released the latest edition of a new report for Congress to better understand the needs of hospitals and health systems during the public health emergency.
The Centers for Medicare & Medicaid Services has identified the Healthcare Common Procedural Coding System codes and Medicare Part B payment allowances effective Nov. 21 for administering casirivimab and imdevimab, a combination monoclonal antibody therapy made by Regeneron.
The Cybersecurity and Infrastructure Security Agency alerted organizations to a global phishing and spearphishing campaign targeting the COVID-19 vaccine cold chain, the part of the supply chain used to store and transport a vaccine at safe temperatures.
The Department of Health and Human Services amended its declaration under the Public Readiness and Emergency Preparedness Act to expand access to COVID-19 medical countermeasures through telehealth and clarify the scope of liability protections.
The AHA will host two important calls for hospital and health system leaders on issues related to the COVID-19 pandemic.
Two hundred twenty-four. That’s the number of days since the last COVID-19 relief package was signed into law.
When setting up a monoclonal antibody (mAb) infusion therapy treatment space, COVI-19 positive patients should be treated in a setting that is readily accessible, separate from any immunocompromised in- or outpatient populations, and proximate from a campus perspective to the pharmacy that would be…